• 2586 Citations
  • 24 Scopus h-Index
20002019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2000 2019

  • 2586 Citations
  • 24 Scopus h-Index
  • 36 Article
  • 3 Review article
  • 1 Editorial
2019

Effects of age and immune landscape on outcome in HER2-positive breast cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) trials

Chumsri, S., Serie, D. J., Li, Z., Pogue-Geile, K. L., Soyano-Muller, A. E., Mashadi-Hossein, A., Warren, S., Lou, Y., Colon-Otero, G., Knutson, K. L., Perez, E. A., Moreno Aspitia, A. & Thompson, E. A., Jan 1 2019, In : Clinical Cancer Research. 25, 14, p. 4422-4430 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
adjuvant P40
B 31
Trastuzumab

Hypereosinophilia in a patient with metastatic non-small-cell lung cancer treated with antiprogrammed cell death 1 (anti-PD-1) therapy

Lou, Y., Marin-Acevedo, J. A., Vishnu, P., Manochakian, R., Dholaria, B., Soyano, A., Luo, Y., Zhang, Y. & Knutson, K. L., May 1 2019, In : Immunotherapy. 11, 7, p. 577-584 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Eosinophilia
Cell Death
Therapeutics
Eosinophils
2 Citations (Scopus)

Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?

Duma, N., Abdel-Ghani, A., Yadav, S., Hoversten, K. P., Reed, C. T., Sitek, A. N., Enninga, E. A. L., Paludo, J., Aguilera, J. V., Leventakos, K., Lou, Y., Kottschade, L. A., Dong, H. M., Mansfield, A., Manochakian, R., Adjei, A. & Dronca, R. S., Jan 1 2019, In : Oncologist.

Research output: Contribution to journalArticle

Programmed Cell Death 1 Receptor
Non-Small Cell Lung Carcinoma
Sex Characteristics
Melanoma
Therapeutics
2018
34 Citations (Scopus)

Cancer immunotherapy beyond immune checkpoint inhibitors

Marin-Acevedo, J. A., Soyano, A. E., Dholaria, B., Knutson, K. L. & Lou, Y., Jan 12 2018, In : Journal of Hematology and Oncology. 11, 1, 8.

Research output: Contribution to journalReview article

Immunotherapy
Immune System
Neoplasms
CD274 Antigen
Programmed Cell Death 1 Receptor
9 Citations (Scopus)

Comprehensive characterization of alternative polyadenylation in human cancer

Xiang, Y., Ye, Y., Lou, Y., Yang, Y., Cai, C., Zhang, Z., Mills, T., Chen, N. Y., Kim, Y., Ozguc, F. M., Diao, L., Karmouty-Quintana, H., Xia, Y., Kellems, R. E., Chen, Z., Blackburn, M. R., Yoo, S. H., Shyu, A. B., Mills, G. B. & Han, L., Apr 1 2018, In : Journal of the National Cancer Institute. 110, 4, p. 379-389 11 p.

Research output: Contribution to journalArticle

Polyadenylation
Neoplasms
Cell Line
mRNA Cleavage and Polyadenylation Factors
Pharmaceutical Preparations
2 Citations (Scopus)

MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: Implications on prognostic immunological biomarker and vaccine design

Cai, W., Zhou, D., Wu, W., Tan, W. L., Wang, J., Zhou, C. & Lou, Y., Aug 3 2018, In : BMC Genomics. 19, 1, 582.

Research output: Contribution to journalArticle

Major Histocompatibility Complex
HLA Antigens
Vaccines
Biomarkers
Peptides
90 Citations (Scopus)

Next generation of immune checkpoint therapy in cancer: New developments and challenges

Marin-Acevedo, J. A., Dholaria, B., Soyano, A. E., Knutson, K. L., Chumsri, S. & Lou, Y., Mar 15 2018, In : Journal of Hematology and Oncology. 11, 1, 39.

Research output: Contribution to journalReview article

CD274 Antigen
Neoplasms
Cytotoxic T-Lymphocytes
Programmed Cell Death 1 Receptor
Therapeutics
9 Citations (Scopus)

Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies

Soyano, A. E., Dholaria, B., Marin-Acevedo, J. A., Diehl, N., Hodge, D., Luo, Y., Manochakian, R., Chumsri, S., Adjei, A., Knutson, K. L. & Lou, Y., Nov 23 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 129.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Cell Death
Lymphocyte Count
Biomarkers
Neutrophils

Post-operative radiation therapy in locally advanced non-small cell lung cancer and the impact of sequential versus concurrent chemotherapy

Waddle, M. R., Ko, S., Johnson, M., Lou, Y., Miller, R. C., Harrell, A. C. & Trifiletti, D., Apr 1 2018, In : Translational Lung Cancer Research. 7, p. S171-S175

Research output: Contribution to journalEditorial

Non-Small Cell Lung Carcinoma
Radiotherapy
Drug Therapy
2 Citations (Scopus)

Survival trends among non-small-cell lung cancer patients over a decade: impact of initial therapy at academic centers

Lou, Y., Dholaria, B., Soyano, A., Hodge, D., Cochuyt, J., Manochakian, R., Ko, S. J., Thomas, M., Johnson, M., Patel, N. M., Miller, R. C., Adjei, A. & Ailawadhi, S., Jan 1 2018, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Survival
Therapeutics
Databases
Neoplasms
16 Citations (Scopus)

The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy

Ye, Y., Xiang, Y., Ozguc, F. M., Kim, Y., Liu, C. J., Park, P. K., Hu, Q., Diao, L., Lou, Y., Lin, C., Guo, A. Y., Zhou, B., Wang, L., Chen, Z., Takahashi, J. S., Mills, G. B., Yoo, S. H. & Han, L., Jan 1 2018, (Accepted/In press) In : Cell Systems.

Research output: Contribution to journalArticle

Chronotherapy
Neoplasm Genes
Pharmacogenetics
Neoplasms
Genes
2017
18 Citations (Scopus)

Cost-effectiveness of pembrolizumab versus docetaxel for the treatment of previously treated PD-L1 positive advanced NSCLC patients in the United States

Huang, M., Lou, Y., Pellissier, J., Burke, T., Liu, F. X., Xu, R. & Velcheti, V., Feb 1 2017, In : Journal of Medical Economics. 20, 2, p. 140-150 11 p.

Research output: Contribution to journalArticle

docetaxel
Quality-Adjusted Life Years
Cost-Benefit Analysis
Lung Neoplasms
Survival
26 Citations (Scopus)

Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States

Huang, M., Lou, Y., Pellissier, J., Burke, T., Liu, F. X., Xu, R. & Velcheti, V., Aug 1 2017, In : PharmacoEconomics. 35, 8, p. 831-844 14 p.

Research output: Contribution to journalArticle

Standard of Care
Non-Small Cell Lung Carcinoma
Cost-Benefit Analysis
Quality-Adjusted Life Years
Ligands
2016
52 Citations (Scopus)

Emerging therapeutic agents for lung cancer

Dholaria, B., Hammond, W., Shreders, A. & Lou, Y., Dec 9 2016, In : Journal of Hematology and Oncology. 9, 1, 138.

Research output: Contribution to journalReview article

Lung Neoplasms
Pharmaceutical Preparations
Therapeutics
Phase II Clinical Trials
Clinical Trials, Phase I
116 Citations (Scopus)

Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinoma

Lou, Y., Diao, L., Cuentas, E. R. P., Denning, W. L., Chen, L., Fan, Y. H., Byers, L. A., Wang, J., Papadimitrakopoulou, V. A., Behrens, C., Rodriguez, J. C., Hwu, P., Wistuba, I. I., Heymach, J. V. & Gibbons, D. L., Jul 15 2016, In : Clinical Cancer Research. 22, 14, p. 3630-3642 13 p.

Research output: Contribution to journalArticle

Epithelial-Mesenchymal Transition
Tumor Microenvironment
Non-Small Cell Lung Carcinoma
Biomarkers
Neoplasms
7 Citations (Scopus)

Germline Mutation of T790M and Dual/Multiple EGFR Mutations in Patients with Lung Adenocarcinoma

Lou, Y., Pecot, C. V., Tran, H. T., Devito, V. J., Tang, X. M., Heymach, J. V., Luthra, R., Wistuba, I. I., Zuo, Z. & Tsao, A. S., Mar 1 2016, In : Clinical Lung Cancer. 17, 2, p. e5-e11

Research output: Contribution to journalArticle

Germ-Line Mutation
Genetic Predisposition to Disease
Epidermal Growth Factor Receptor
Lung Neoplasms
Adenocarcinoma
3 Citations (Scopus)

Molecular basis of antibody binding to mucin glycopeptides in lung cancer

Qu, J., Yu, H., Li, F., Zhang, C., Trad, A., Brooks, C., Zhang, B., Gong, T., Guo, Z., Li, Y., Ragupathi, G., Lou, Y., Hwu, P., Huang, W. & Zhou, D., Feb 1 2016, In : International Journal of Oncology. 48, 2, p. 587-594 8 p.

Research output: Contribution to journalArticle

Tandem Repeat Sequences
Glycopeptides
Mucins
Lung Neoplasms
Antibodies
2013
174 Citations (Scopus)

BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice

Liu, C., Peng, W., Xu, C., Lou, Y., Zhang, M., Wargo, J. A., Chen, J. Q., Li, H. S., Watowich, S. S., Yang, Y., Frederick, D. T., Cooper, Z. A., Mbofung, R. M., Whittington, M., Flaherty, K. T., Woodman, S. E., Davies, M. A., Radvanyi, L. G., Overwijk, W. W., Lizée, G. & 1 others, Hwu, P., Jan 15 2013, In : Clinical Cancer Research. 19, 2, p. 393-403 11 p.

Research output: Contribution to journalArticle

Adoptive Immunotherapy
T-Lymphocytes
Vascular Endothelial Growth Factor A
Melanoma
Neoplasms
212 Citations (Scopus)

Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion

Hailemichael, Y., Dai, Z., Jaffarzad, N., Ye, Y., Medina, M. A., Huang, X. F., Dorta-Estremera, S. M., Greeley, N. R., Nitti, G., Peng, W., Liu, C., Lou, Y., Wang, Z., Ma, W., Rabinovich, B., Schluns, K. S., Davis, R. E., Hwu, P. & Overwijk, W. W., Apr 2013, In : Nature Medicine. 19, 4, p. 465-472 8 p.

Research output: Contribution to journalArticle

T-cells
Tumors
Vaccination
T-Lymphocytes
Antigens
2012
20 Citations (Scopus)

Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo

Liu, C., Lewis, C. M., Lou, Y., Xu, C., Peng, W., Yang, Y., Gelbard, A. H., Lizée, G., Zhou, D., Overwijk, W. W. & Hwu, P., Apr 2012, In : Journal of Immunotherapy. 35, 3, p. 276-282 7 p.

Research output: Contribution to journalArticle

T-Lymphocytes
Antibodies
Monoclonal Antibodies
Interleukin-12
Interleukin-2
182 Citations (Scopus)

PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines

Peng, W., Liu, C., Xu, C., Lou, Y., Chen, J., Yang, Y., Yagita, H., Overwijk, W. W., Lizeé, G., Radvanyi, L. & Hwu, P., Oct 15 2012, In : Cancer Research. 72, 20, p. 5209-5218 10 p.

Research output: Contribution to journalArticle

Chemokines
Cell Movement
Cell Death
T-Lymphocytes
Adoptive Transfer
2011
32 Citations (Scopus)

Antitumor activity mediated by CpG: The route of administration is critical

Lou, Y., Liu, C., Lizée, G., Peng, W., Xu, C., Ye, Y., Rabinovich, B. A., Hailemichael, Y., Gelbard, A., Zhou, D., Overwijk, W. W. & Hwu, P., Apr 2011, In : Journal of Immunotherapy. 34, 3, p. 279-288 10 p.

Research output: Contribution to journalArticle

T-Lymphocytes
Neoplasm Antigens
Neoplasms
Chemokines
Intravenous Injections
2010
95 Citations (Scopus)

Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses

Peng, W., Ye, Y., Rabinovich, B. A., Liu, C., Lou, Y., Zhang, M., Whittington, M., Yang, Y., Overwijk, W. W., Lizée, G. & Hwu, P., Nov 15 2010, In : Clinical Cancer Research. 16, 22, p. 5458-5468 11 p.

Research output: Contribution to journalArticle

Interleukin-8B Receptors
Chemokine Receptors
T-Lymphocytes
Neoplasms
Luciferases
2009
74 Citations (Scopus)

IFN-α enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity

Sikora, A. G., Jaffarzad, N., Hailemichael, Y., Gelbard, A., Stonier, S. W., Schluns, K. S., Frasca, L., Lou, Y., Liu, C., Andersson, H. A., Hwu, P. & Overwijk, W. W., Jun 15 2009, In : Journal of Immunology. 182, 12, p. 7398-7407 10 p.

Research output: Contribution to journalArticle

Subunit Vaccines
Vaccination
Cell Count
T-Lymphocytes
Peptides
27 Citations (Scopus)

Vaccine site inflammation potentiates idiotype DNAvaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunity

Qin, H., Cha, S. C., Neelapu, S. S., Lou, Y., Wei, J., Liu, Y. J. & Kwak, L. W., Nov 5 2009, In : Blood. 114, 19, p. 4142-4149 8 p.

Research output: Contribution to journalArticle

T-cells
Immunity
B-Lymphocytes
Vaccines
Cells
2008
193 Citations (Scopus)

Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice

Liu, C., Lou, Y., Lizée, G., Qin, H., Liu, S., Rabinovich, B., Kim, G. J., Wang, Y. H., Ye, Y., Sikora, A. G., Overwijk, W. W., Liu, Y. J., Wang, G. & Hwu, P., Mar 2008, In : Journal of Clinical Investigation. 118, 3, p. 1165-1175 11 p.

Research output: Contribution to journalArticle

Cross-Priming
Neoplasm Antigens
Natural Killer Cells
Dendritic Cells
T-Lymphocytes
2007
63 Citations (Scopus)

IL-21 synergizes with IL-7 to augment expansion and anti-tumor function of cytotoxic T cells

Liu, S., Lizée, G., Lou, Y., Liu, C., Overwijk, W. W., Wang, G. & Hwu, P., Oct 2007, In : International Immunology. 19, 10, p. 1213-1221 9 p.

Research output: Contribution to journalArticle

Interleukin-7
T-Lymphocytes
Neoplasms
Interleukin-7 Receptor alpha Subunit
Cytokines
86 Citations (Scopus)

Plasmacytoid dendritic cells synergize with myeloid dendritic cells in the induction of antigen-specific antitumor immune responses

Lou, Y., Liu, C., Kim, G. J., Liu, Y. J., Hwu, P. & Wang, G., Feb 1 2007, In : Journal of Immunology. 178, 3, p. 1534-1541 8 p.

Research output: Contribution to journalArticle

Myeloid Cells
Dendritic Cells
Antigens
T-Lymphocytes
Immunization
2006
13 Citations (Scopus)

Thio-isoglobotrihexosylceramide, an agonist for activating invariant natural killer T cells

Xia, C., Zhou, D., Liu, C., Lou, Y., Yao, Q., Zhang, W. & Wang, P. G., Nov 23 2006, In : Organic Letters. 8, 24, p. 5493-5496 4 p.

Research output: Contribution to journalArticle

lysosomes
Natural Killer T-Cells
T-cells
antigens
retaining
2005
20 Citations (Scopus)

Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptor

Hu, B., Wei, Y., Tian, L., Zhao, X., Lu, Y., Wu, Y., Yao, B., Liu, J., Niu, T., Wen, Y., He, Q., Su, J., Huang, M., Lou, Y., Luo, Y. & Kan, B., May 2005, In : Journal of Immunotherapy. 28, 3, p. 236-244 9 p.

Research output: Contribution to journalArticle

Active Immunity
Epidermal Growth Factor Receptor
Vaccines
Adoptive Transfer
Neoplasms
27 Citations (Scopus)

Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities

Hou, J. M., Liu, J. Y., Yang, L., Zhao, X., Tian, L., Ding, Z. Y., Wen, Y. J., Niu, T., Xiao, F., Lou, Y., Tan, G. H., Deng, H. X., Li, J., Yang, J. L., Mao, Y. Q. & Wei, Y. Q., Aug 2005, In : Oncology. 69, 1, p. 81-87 7 p.

Research output: Contribution to journalArticle

gemcitabine
Vascular Endothelial Growth Factor Receptor-2
Quail
Vaccines
Neoplasms
2004
91 Citations (Scopus)

Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo

Lou, Y., Wang, G., Lizée, G., Kim, G. J., Finkelstein, S. E., Feng, C., Restifo, N. P. & Hwu, P., Sep 15 2004, In : Cancer Research. 64, 18, p. 6783-6790 8 p.

Research output: Contribution to journalArticle

Dendritic Cells
T-Lymphocytes
Vaccination
Antigens
Neoplasms
2003
65 Citations (Scopus)

Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-21

Su, J. M., Wei, Y. Q., Tian, L., Zhao, X., Yang, L., He, Q. M., Wang, Y., Lu, Y., Wu, Y., Liu, F., Liu, J. Y., Yang, J. L., Lou, Y., Hu, B., Niu, T., Wen, Y. J., Xiao, F., Deng, H. X., Li, J. & Kan, B., Feb 1 2003, In : Cancer Research. 63, 3, p. 600-607 8 p.

Research output: Contribution to journalArticle

Cancer Vaccines
Matrix Metalloproteinase 2
Matrix Metalloproteinases
Chickens
Neoplasms
120 Citations (Scopus)

Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2

Liu, J. Y., Wei, Y. Q., Yang, L., Zhao, X., Tian, L., Hou, J. M., Niu, T., Liu, F., Jiang, Y., Hu, B., Wu, Y., Su, J. M., Lou, Y., He, Q. M., Wen, Y. J., Yang, J. L., Kan, B., Mao, Y. Q., Luo, F. & Peng, F., Sep 1 2003, In : Blood. 102, 5, p. 1815-1823 9 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor Receptor-2
Cancer Vaccines
Quail
Immunotherapy
Tumors
72 Citations (Scopus)

Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice

He, Q. M., Wei, Y. Q., Tian, L., Zhao, X., Su, J. M., Yang, L., Lu, Y., Kan, B., Lou, Y., Huang, M. J., Xiao, F., Liu, J. Y., Hu, B., Luo, F., Jiang, Y., Wen, Y. J., Deng, H. X., Li, J., Niu, T. & Yang, J. L., Jun 13 2003, In : Journal of Biological Chemistry. 278, 24, p. 21831-21836 6 p.

Research output: Contribution to journalArticle

Receptor, Fibroblast Growth Factor, Type 1
Tumors
Vaccines
Immune Tolerance
Growth
192 Citations (Scopus)

In Vivo Antitumor Activity of Interleukin 21 Mediated by Natural Killer Cells

Wang, G., Tschoi, M., Spolski, R., Lou, Y., Ozaki, K., Feng, C., Kim, G., Leonard, W. J. & Hwu, P., Dec 15 2003, In : Cancer Research. 63, 24, p. 9016-9022 7 p.

Research output: Contribution to journalArticle

Natural Killer Cells
Interleukin-2
Plasmids
DNA
Neoplasms
2002
70 Citations (Scopus)

A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin

Xiao, F., Wei, Y., Yang, L., Zhao, X., Tian, L., Ding, Z., Yuan, S., Lou, Y., Liu, F., Wen, Y., Li, J., Deng, H., Kang, B., Mao, Y., Lei, S., He, Q., Su, J., Lu, Y., Niu, T., Hou, J. & 1 others, Huang, M. J., 2002, In : Gene Therapy. 9, 18, p. 1207-1213 7 p.

Research output: Contribution to journalArticle

Angiogenesis Inhibitors
Genetic Therapy
Neoplasms
COS Cells
Plasmids
19 Citations (Scopus)

Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin β3

Lou, Y., Wei, Y. Q., Yang, L., Zhao, X., Tian, L., Lu, Y., Wen, Y. J., Liu, F., Huang, M. J., Kang, B., Xiao, F., Su, J. M., He, Q. M., Xie, X. J., Mao, Y. Q., Lei, S., Liu, J. Y., Lou, F., Zhou, L. Q., Peng, F. & 2 others, Jiang, Y. & Hu, B., 2002, In : Immunological Investigations. 31, 1, p. 51-69 19 p.

Research output: Contribution to journalArticle

Integrins
Chickens
Vaccines
Ligands
Neoplasms
2001
126 Citations (Scopus)

Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen

Wei, Y. Q., Huang, M. J., Yang, L., Zhao, X., Tian, L., Lu, Y., Shu, J. M., Lu, C. J., Niu, T., Kang, B., Mao, Y. Q., Liu, F., Wen, Y. J., Lei, S., Luo, F., Zhou, L. Q., Peng, F., Jiang, Y., Liu, J. Y., Zhou, H. & 11 others, Wang, Q. R., He, Q. M., Xiao, F., Lou, Y., Xie, X. J., Li, Q., Wu, Y., Ding, Z. Y., Hu, B., Hu, M. & Zhang, W., Sep 25 2001, In : Proceedings of the National Academy of Sciences of the United States of America. 98, 20, p. 11545-11550 6 p.

Research output: Contribution to journalArticle

Cancer Vaccines
Xenopus
Vascular Endothelial Growth Factor A
Antigens
Neoplasms
2000
227 Citations (Scopus)

Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine

Wei, Y. Q., Wang, Q. R., Zhao, X., Yang, L., Tian, L., Lu, Y., Kang, B., Lu, C. J., Huang, M. J., Lou, Y., Xiao, F., He, Q. M., Shu, J. M., Xie, X. J., Mao, Y. Q., Lei, S., Luo, F., Zhou, L. Q., Liu, C. E., Zhou, H. & 6 others, Jiang, Y., Peng, F., Yuan, L. P., Li, Q., Wu, Y. & Liu, J. Y., 2000, In : Nature Medicine. 6, 10, p. 1160-1166 7 p.

Research output: Contribution to journalArticle

Endothelial cells
Immunotherapy
Tumors
Vaccines
Endothelial Cells